Has Svitlana Mandzy received payments from drug or device companies?

Yes. Drug and device makers reported $1,746 in general payments to Svitlana Mandzy across 98 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Svitlana Mandzy did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Svitlana Mandzy come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Svitlana Mandzy

Geriatric Medicine · Louisville, KYNPI 1750375861

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Pfizer at 25.1% of the total.

$1,746in general payments, 2019–2025

Across 98 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$438
Amgen$227
Novo Nordisk$225
Amarin Pharma, Inc.$220
AstraZeneca$174
Astellas Pharma US Inc$112
plus $351 from 13 others

What the payments were for

Food & beverage$1,73499%
Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	18	$438
Amgen	15	$227
Novo Nordisk	13	$225
Amarin Pharma, Inc.	12	$220
AstraZeneca	7	$174
Astellas Pharma US Inc	7	$112
AbbVie(2 entities)	4	$66
Lilly USA, LLC	5	$62
Takeda Pharmaceuticals U.S.A., Inc.	3	$37
Promius Pharma LLC	2	$33
Novartis	2	$27
Currax Pharmaceuticals LLC	2	$26
Boehringer Ingelheim	2	$22
Johnson & Johnson	1	$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$14
E.r. Squibb & Sons, L.L.C.	1	$12
Circassia Inc.	1	$12
MDD US Operations, LLC	1	$12
Vivus LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,746 in reported general payments places this provider in the 75th percentile of 33 geriatric medicine providers in Kentucky.

See all geriatric medicine providers in Kentucky →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	14	$708
Levothyroxine Sodium	16	$180
Atorvastatin Calcium	12	$80
Lisinopril	18	$46
Metformin Hcl	13	$18

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in Louisville

Rachel HartLouisville$34K
Josephine GomesLouisville$11K
Christian FurmanLouisville$667
Bhagyalaxmi RudravaramLouisville$370
Kenneth PughLouisville$223
Claudiu MoisaLouisville$168
Arif NazirLouisville$87
Kelly ChurchLouisville$29
James ObrienLouisville$16
Patrick MurphyLouisville$13

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →